Literature DB >> 27742881

The effect of dichloroacetate on male rat thymus and on thymocyte cell cycle.

Jurate Stanevičiūtė1, Daiva Urbonienė2, Angelija Valančiūtė1, Ingrida Balnytė1, Astra Vitkauskienė2, Brigita Grigalevičienė3, Donatas Stakišaitis4,5.   

Abstract

The study aim was to investigate the effect of dichloroacetate (DCA) on thymus and the thymocyte cycle in rats. Wistar male gonad-intact and castrated rats (4-5 weeks) were investigated in the following groups: (1) control; (2) treated with DCA; and (3) treated with the DCA and sodium valproate (NaVP) combination. Rats were treated for 4 weeks with DCA 200 mg/kg/day alone and 300 mg/kg/day of NaVP plus 200 mg/kg/day of DCA (every second week, beginning with NaVP). After the experiment, the thymus was weighted, and the thymus lobe was taken for thymocyte flow cytometry. In gonad-intact rats, the thymus weight of the control was higher than in rats treated with DCA (P <0.001) or with the NaVP-DCA combination (P <0.04); a comparison of thymus weight between DCA- and NaVP-DCA-treated groups revealed a higher thymus weight loss in the DCA-treated group (P <0.03). Flow cytometry shows that DCA treatment increased the percentage of cells in the G2-M phase (P <0.03) and reduced in G1-G0 (P <0.02). The DCA treatment effect was determined only in gonad-intact but not in castrated rats. The authors discuss the possible DCA and NaVP interaction mechanisms.
© The Author(s) 2016.

Entities:  

Keywords:  dichloroacetate; rats; sodium valproate; thymocyte; thymus

Mesh:

Substances:

Year:  2016        PMID: 27742881      PMCID: PMC5806848          DOI: 10.1177/0394632016674019

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  15 in total

1.  The effect of valproate and levetiracetam on steroidogenesis in forskolin-stimulated H295R cells.

Authors:  Kristine von Krogh; Hannah Harjen; Camilla Almås; Karin E Zimmer; Ellen Dahl; Ingrid Olsaker; Erik Taubøll; Erik Ropstad; Steven Verhaegen
Journal:  Epilepsia       Date:  2010-08-17       Impact factor: 5.864

2.  Sodium valproate effect on the structure of rat glandule thymus: Gender-related differences.

Authors:  Angelija Valančiūtė; Raminta Mozuraitė; Ingrida Balnytė; Janina Didžiapetrienė; Paulius Matusevičius; Donatas Stakišaitis
Journal:  Exp Toxicol Pathol       Date:  2015-04-28

Review 3.  Pharmacokinetics, metabolism and toxicology of dichloroacetate.

Authors:  P W Stacpoole; G N Henderson; Z Yan; R Cornett; M O James
Journal:  Drug Metab Rev       Date:  1998-08       Impact factor: 4.518

4.  Chloride and other anions inhibit dichloroacetate-induced inactivation of human liver GSTZ1 in a haplotype-dependent manner.

Authors:  Guo Zhong; Wenjun Li; Yuan Gu; Taimour Langaee; Peter W Stacpoole; Margaret O James
Journal:  Chem Biol Interact       Date:  2014-03-13       Impact factor: 5.192

5.  Synergistic anticancer potential of dichloroacetate and estradiol analogue exerting their effect via ROS-JNK-Bcl-2-mediated signalling pathways.

Authors:  Xiao Xing Stander; Barend André Stander; Annie Margaretha Joubert
Journal:  Cell Physiol Biochem       Date:  2015-03-12

6.  Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate.

Authors:  Peter W Stacpoole; Lesa R Gilbert; Richard E Neiberger; Paul R Carney; Edward Valenstein; Douglas W Theriaque; Jonathan J Shuster
Journal:  Pediatrics       Date:  2008-04-14       Impact factor: 7.124

7.  Dichloroacetic acid: metabolism in cytosol.

Authors:  J C Lipscomb; D A Mahle; W T Brashear; H A Barton
Journal:  Drug Metab Dispos       Date:  1995-11       Impact factor: 3.922

8.  Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid.

Authors:  Tomasz Schneider; Adam Roman; Agnieszka Basta-Kaim; Marta Kubera; Bogusława Budziszewska; Karolina Schneider; Ryszard Przewłocki
Journal:  Psychoneuroendocrinology       Date:  2008-04-08       Impact factor: 4.905

9.  Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib.

Authors:  W Y Sanchez; S L McGee; T Connor; B Mottram; A Wilkinson; J P Whitehead; S Vuckovic; L Catley
Journal:  Br J Cancer       Date:  2013-03-26       Impact factor: 7.640

10.  Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3.

Authors:  Chiara Agnoletto; Elisabetta Melloni; Fabio Casciano; Gian Matteo Rigolin; Erika Rimondi; Claudio Celeghini; Laura Brunelli; Antonio Cuneo; Paola Secchiero; Giorgio Zauli
Journal:  Oncotarget       Date:  2014-06-30
View more
  3 in total

1.  Sodium Dichloroacetate Pharmacological Effect as Related to Na-K-2Cl Cotransporter Inhibition in Rats.

Authors:  Jūratė Stanevičiūtė; Milda Juknevičienė; Jolita Palubinskienė; Ingrida Balnytė; Angelija Valančiūtė; Rūta Vosyliūtė; Kęstutis Sužiedėlis; Vaiva Lesauskaitė; Donatas Stakišaitis
Journal:  Dose Response       Date:  2018-11-20       Impact factor: 2.658

2.  Gender-Related Effect of Sodium Dichloroacetate on the Number of Hassall's Corpuscles and RNA NKCC1 Expression in Rat Thymus.

Authors:  Jūratė Stanevičiūtė; Milda Juknevičienė; Ingrida Balnytė; Angelija Valančiūtė; Vaiva Lesauskaitė; Julija Fadejeva; Rimantas Stakauskas; Donatas Stakišaitis
Journal:  Biomed Res Int       Date:  2019-04-24       Impact factor: 3.411

Review 3.  The Importance of Gender-Related Anticancer Research on Mitochondrial Regulator Sodium Dichloroacetate in Preclinical Studies In Vivo.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Eligija Damanskienė; Angelija Valančiūtė; Ingrida Balnytė; Marta Maria Alonso
Journal:  Cancers (Basel)       Date:  2019-08-20       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.